Innovative Bioprinting VivoSim Labs specializes in cutting-edge 3D bioprinting technology to develop human-like tissue models, presenting opportunities for partnerships in advanced biotech manufacturing and research equipment suppliers.
Regulatory Achievement The company's recent award at Digestive Disease Week underscores its industry recognition and credibility, making it a promising partner for healthcare providers and research institutions seeking innovative therapeutic solutions.
Growing Market Presence With a revenue range of 10 to 25 million dollars and participation in prominent scientific events, VivoSim is expanding its footprint in the biotech research community, indicating potential for collaboration with pharmaceutical and biotech firms.
Tech Stack & Infrastructure Utilizing advanced platforms like Akamai, MySQL, and Acquia Cloud, VivoSim demonstrates its commitment to robust and scalable technology solutions, offering opportunities for technology providers aiming to enhance biotech R&D infrastructure.
Collaborative Opportunities Focusing on human primary cell 3D models that recapitulate disease processes, VivoSim presents opportunities for joint development, licensing, or technology integration with companies focused on drug discovery, personalized medicine, or research tools.